-Business Standard This would be in addition to 348 drugs already under price ceiling The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck. This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin...

-The Times of India NEW DELHI: The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops. Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a...

-The Tribune BARC reports toxic metals in fertilisers as firms avoid costly decontamination process Bathinda (Punjab): The Bhabha Atomic Research Centre (BARC) has found high uranium content in diammonium phosphate and single superphosphate fertilisers that do not undergo the costlier decontamination process during production. The conclusion was reached after testing of soil and fertiliser samples. The Environmental Assessment Division of BARC sent a report on samples of DAP (diammonium phosphate) and single superphosphate...

-The Telegraph Calcutta: Private Companies will be able to buy farm produce directly from farmers in Bengal. But the widely-anticipated whoop of exultation from Indian industry over the amendment in the state's agri-marketing act was somewhat muted because of the lack of clarity on the issue of contract farming and the absence of clear guidelines on whether the state government would provide incentives and help in the acquisition of land for private...

-Business Standard Domestic regulators need to be stricter about quality violations to protect both Indian pharma exports as well as the country's image Even as major Indian drug Companies continue to make news for impurities in the medicines they make and faulty - or if the USFDA is to be believed, falsified - data that many generate after testing of samples show quality problem, it seems strange that domestic authorities are silent...